RFK Jr.’s embrace of psychedelic therapy sparks mixed feelings from field experts
Global News
United States Health Secretary Robert F. Kennedy Jr. recently told members of Congress that clinical psychedelic therapy treatments could be approved within 12 months.
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions.
A presidential administration finally seems to agree.
“This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,” Health Secretary Robert F. Kennedy Jr. recently told members of Congress.
His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs. And it comes as psychedelics are making inroads in deep red states like Texas, where former Trump cabinet secretary and ex-governor Rick Perry has thrown his full support behind the effort.
The administration’s embrace of psychedelics has sparked both excitement as well as concern from those in the field, who worry the drugs might be discredited if they appear to be rushed onto the market or are too closely linked with Kennedy, who is known for controversial views on vaccines, antidepressants and fluoride.
“I’m quite optimistic,” says Rick Doblin, whose organization has pursed the medical use of MDMA (or ecstasy) since the 1980s. “But I’m also worried that the message the public might get is ‘Well, RFK likes psychedelics and now it’s approved.’”
FDA may reconsider MDMA Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and questionable research. Regulators called for a new study, likely taking several years. It was a major setback for Doblin and other advocates hoping to see the first U.S. approval of a psychedelic for medical use.
But the agency appears ready to reconsider. FDA chief Marty Makary, who reports to Kennedy, has called the evaluation of MDMA and other psychedelics “a top priority,” announcing a slate of initiatives that could be used to accelerate their approval.
Some experts say that a cyberwar through 'proxies' may be the next stage of the Iran war, with civilian infrastructure also coming under threat.
The study is being billed by the university as "the first to study a wide range of factors which link ADHD symptoms and mental ill health symptoms over time."
The group says MAGA Energy hasn't paid its lease for three years, and therefore the company is no longer allowed on their land in Edmonton.
The analysis by the Canadian Climate Institute says oilsands producers will pay an average of about 50 cents per oil barrel, if the minimum carbon price rises to $130 per tonne.
Between November 29 and February 27, authorities recorded 406 outbreaks of bird flu in domestic birds in 32 European countries and 2,108 outbreaks in wild birds, they said.
Dr. Michael Domeier, director of the Marine Conservation Science Institute, told Global News that they tag the adult females as they are the most interesting.
Regina’s recycling contamination is currently triple the limit and city is urging resident to change sorting habits now to avoid citywide fines and higher resident fees.
The study found that higher ultra-processed food intake at age three years was associated with adverse behavioural and emotional symptoms at age five years.
Edmonton's single-use waste rules were controversial and unpopular when introduced in 2023 — but new data shows the changes are having the intended effect of reducing garbage.
Carney's speech to Australia's parliament highlighted a soon-to-launch Canadian low earth orbit satellite network that experts say could soon compete with Elon Musk's Starlink.
The Pentagon said in a statement Thursday that it has “officially informed Anthropic leadership the company and its products are deemed a supply chain risk, effective immediately.”
Opioid overdose deaths in Canada are falling, but there's growing concerns on a certain veterinary tranquilizer being cut into fentanyl and other opioids.
The product is being recalled in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan due to 'undeclared almonds' being found.